메뉴 건너뛰기




Volumn 31, Issue 5, 2013, Pages 756-760

Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome

Author keywords

Antiphospholipid antibodies; Cardiac manifestations; Non thrombotic neurological manifestations

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

EID: 84884943484     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (24)

References (40)
  • 1
    • 0033834033 scopus 로고    scopus 로고
    • Epidemiology of the antiphospholipid antibody syndrome
    • PETRI M: Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000; 15: 145-51.
    • (2000) J Autoimmun , vol.15 , pp. 145-51
    • Petri, M.1
  • 2
    • 0027292423 scopus 로고
    • The antiphospholipid syndrome: ten years on
    • HUGHES GR: The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-4.
    • (1993) Lancet , vol.342 , pp. 341-4
    • Hughes, G.R.1
  • 3
    • 0033512274 scopus 로고    scopus 로고
    • International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop
    • WILSON WA, GHARAVI AE, KOIKE T, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
    • (1999) Arthritis Rheum , vol.42 , pp. 1309-11
    • Wilson, W.A.1    Gharavi, A.E.2    Koike, T.3
  • 6
    • 33746628584 scopus 로고    scopus 로고
    • Autoimmune hemolytic anaemia in the antiphospholipid syndrome
    • ROTTEM M, KRAUSE I, FRASER A, et al: Autoimmune hemolytic anaemia in the antiphospholipid syndrome. Lupus 2006; 15: 473-7.
    • (2006) Lupus , vol.15 , pp. 473-7
    • Rottem, M.1    Krause, I.2    Fraser, A.3
  • 9
    • 0036228886 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
    • CERVERA R, PIETTE JC, FONT J, et al: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-27.
    • (2002) Arthritis Rheum , vol.46 , pp. 1019-27
    • Cervera, R.1    Piette, J.C.2    Font, J.3
  • 10
    • 0038485978 scopus 로고    scopus 로고
    • Long term outcome of catastrophic antiphospholipid syndrome survivors
    • ERKAN D, ASHERSON RA, ESPINOSA G, et al: Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis 2003; 62: 530-33.
    • (2003) Ann Rheum Dis , vol.62 , pp. 530-33
    • Erkan, D.1    Asherson, R.A.2    Espinosa, G.3
  • 11
    • 33947723342 scopus 로고    scopus 로고
    • Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases
    • STOJANOVICH L, MILOVANOVICH B, de LUKA SR, et al: Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases. Lupus 2007; 16: 181-5.
    • (2007) Lupus , vol.16 , pp. 181-5
    • Stojanovich, L.1    Milovanovich, B.2    de Luka, S.R.3
  • 12
    • 0037405490 scopus 로고    scopus 로고
    • Antiphospholipid antibodies and infections
    • ASHERSON RA, CERVERA R: Antiphospholipid antibodies and infections. Ann Rheum Dis 2003; 62: 388-93.
    • (2003) Ann Rheum Dis , vol.62 , pp. 388-93
    • Asherson, R.A.1    Cervera, R.2
  • 13
    • 0033984834 scopus 로고    scopus 로고
    • Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature
    • Cuadrado MJ, KHAMASHTA MA, BALLESTEROS A, GODFREY T, SIMON MJ, HUGHES GR: Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000; 79: 57-68.
    • (2000) Medicine (Baltimore) , vol.79 , pp. 57-68
    • Cuadrado, M.J.1    Khamashta, M.A.2    Ballesteros, A.3    Godfrey, T.4    Simon, M.J.5    Hughes, G.R.6
  • 14
    • 77951234806 scopus 로고    scopus 로고
    • Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'. Cervera R; CAPS Registry Project Group
    • KAUL M: Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'. Cervera R; CAPS Registry Project Group. Lupus 2010; 19: 412-8.
    • (2010) Lupus , vol.19 , pp. 412-8
    • Kaul, M.1
  • 15
    • 66349095456 scopus 로고    scopus 로고
    • The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems
    • STOJANOVICH L: The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems. Clin Rev Allergy Immunol 2009; 36: 98-103.
    • (2009) Clin Rev Allergy Immunol , vol.36 , pp. 98-103
    • Stojanovich, L.1
  • 16
    • 0020436689 scopus 로고
    • The 1982 revised criteria for the classification of systemic lupus erythematosus
    • TAN EM, COHEN AS, FRIES JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
    • (1982) Arthritis Rheum , vol.25 , pp. 1271-7
    • Tan, E.M.1    Cohen, A.S.2    Fries, J.F.3
  • 17
    • 0012008982 scopus 로고    scopus 로고
    • Reliability of SELENA, SLEDAI and flare as clinical trial outcome measures
    • PETRI M, BUYON J, SKOVRON ML, et al: Reliability of SELENA, SLEDAI and flare as clinical trial outcome measures. Arthritis Rheum 1998; 41: 218.
    • (1998) Arthritis Rheum , vol.41 , pp. 218
    • Petri, M.1    Buyon, J.2    Skovron, M.L.3
  • 18
    • 0142008980 scopus 로고    scopus 로고
    • Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography
    • ZOGHBI WA, ENRIQUEZ-SARANO M, FOSTER E, et al: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
    • (2003) J Am Soc Echocardiogr , vol.16 , pp. 777-802
    • Zoghbi, W.A.1    Enriquez-Sarano, M.2    Foster, E.3
  • 20
    • 26244446531 scopus 로고    scopus 로고
    • Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome
    • KRAUSE I, LEV S, FRASER A, et al: Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis 2005; 64: 1490-3.
    • (2005) Ann Rheum Dis , vol.64 , pp. 1490-3
    • Krause, I.1    Lev, S.2    Fraser, A.3
  • 21
    • 3042727917 scopus 로고    scopus 로고
    • Features associated with epilepsy in the antiphospholipid syndrome
    • SHOENFELD Y, LEV S, BLATT I, et al: Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol 2004; 31: 1344-8.
    • (2004) J Rheumatol , vol.31 , pp. 1344-8
    • Shoenfeld, Y.1    Lev, S.2    Blatt, I.3
  • 22
    • 0025124929 scopus 로고
    • Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases
    • LEVINE SR, DEEGAN MJ, FUTRELL N, WELCH KM: Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181-9.
    • (1990) Neurology , vol.40 , pp. 1181-9
    • Levine, S.R.1    Deegan, M.J.2    Futrell, N.3    Welch, K.M.4
  • 24
    • 33646272440 scopus 로고    scopus 로고
    • Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome)
    • CIMAZ R, MERONI PL, SHOENFELD Y: Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Lupus 2006; 15: 191-7.
    • (2006) Lupus , vol.15 , pp. 191-7
    • Cimaz, R.1    Meroni, P.L.2    Shoenfeld, Y.3
  • 25
    • 34047106679 scopus 로고    scopus 로고
    • Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome
    • ZANDMAN-GODDARD G, CHAPMAN J, SHOENFELD Y: Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007; 36: 297-315.
    • (2007) Semin Arthritis Rheum , vol.36 , pp. 297-315
    • Zandman-Goddard, G.1    Chapman, J.2    Shoenfeld, Y.3
  • 26
    • 0033060155 scopus 로고    scopus 로고
    • Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease
    • AMITAL H, LANGEVITZ P, LEVY Y, et al: Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Clin Exp Rheumatol 1999; 17: 99-102.
    • (1999) Clin Exp Rheumatol , vol.17 , pp. 99-102
    • Amital, H.1    Langevitz, P.2    Levy, Y.3
  • 27
    • 38849123295 scopus 로고    scopus 로고
    • Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study
    • BIDOT CJ, HORSTMAN LL, JY W, et al: Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol 2007; 7: 36.
    • (2007) BMC Neurol , vol.7 , pp. 36
    • Bidot, C.J.1    Horstman, L.L.2    Jy, W.3
  • 28
    • 0031921018 scopus 로고    scopus 로고
    • Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study
    • TOURBAH A, CLAPIN A, GOUT O, et al: Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study. Arch Neurol 1998; 55: 517-21.
    • (1998) Arch Neurol , vol.55 , pp. 517-21
    • Tourbah, A.1    Clapin, A.2    Gout, O.3
  • 29
    • 34250690512 scopus 로고    scopus 로고
    • Neurologic manifestations of the antiphospholipid syndrome
    • ROLDAN JF, BREY RL: Neurologic manifestations of the antiphospholipid syndrome. Curr Rheumatol Rep 2007; 9: 109-15.
    • (2007) Curr Rheumatol Rep , vol.9 , pp. 109-15
    • Roldan, J.F.1    Brey, R.L.2
  • 30
    • 33751021370 scopus 로고    scopus 로고
    • Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings
    • TEKTONIDOU MG, VARSOU N, KOTOULAS G, ANTONIOU A, MOUTSOPOULOS HM: Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 2006; 166: 2278-84.
    • (2006) Arch Intern Med , vol.166 , pp. 2278-84
    • Tektonidou, M.G.1    Varsou, N.2    Kotoulas, G.3    Antoniou, A.4    Moutsopoulos, H.M.5
  • 31
    • 33746352779 scopus 로고    scopus 로고
    • Cerebral manifestations in the antiphospholipid (Hughes) syndrome
    • SANNA G, D'CRUZ D, CUADRADO MJ: Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Rheum Dis Clin North Am 2006; 32: 465-90.
    • (2006) Rheum Dis Clin North Am , vol.32 , pp. 465-90
    • Sanna, G.1    D'Cruz, D.2    Cuadrado, M.J.3
  • 35
    • 78751477751 scopus 로고    scopus 로고
    • The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    • NARSHI CB, GILES IP, RAHMAN A: The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus? Lupus 2011; 20: 5-13.
    • (2011) Lupus , vol.20 , pp. 5-13
    • Narshi, C.B.1    Giles, I.P.2    Rahman, A.3
  • 36
    • 78751492207 scopus 로고    scopus 로고
    • Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity
    • JARPA E, BABUL M, CALDERÓN J, et al: Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus 2011; 20: 58-66.
    • (2011) Lupus , vol.20 , pp. 58-66
    • Jarpa, E.1    Babul, M.2    Calderón, J.3
  • 37
    • 84855165886 scopus 로고    scopus 로고
    • Italian Society of Rheumatology. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients
    • (Oxford)
    • GOVONI M, BOMBARDIERI S, BORTOLUZZI A, et al; Italian Society of Rheumatology: Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) 2012; 51: 157-68.
    • (2012) Rheumatology , vol.51 , pp. 157-68
    • Govoni, M.1    Bombardieri, S.2    Bortoluzzi, A.3
  • 38
  • 39
    • 84878370351 scopus 로고    scopus 로고
    • The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome
    • HERNÁNDEZ-MOLINA G, ESPERICUETAARRIOLA G, CABRAL AR: The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome. Clin Exp Rheumatol 2013; 31: 382-8.
    • (2013) Clin Exp Rheumatol , vol.31 , pp. 382-8
    • Hernández-Molina, G.1    Espericuetaarriola, G.2    Cabral, A.R.3
  • 40
    • 84875776552 scopus 로고    scopus 로고
    • Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study
    • STOJANOVICH L, KONTIC M, DJOKOVIC A, et al: Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study. Clin Exp Rheumatol 2013; 31: 234-42.
    • (2013) Clin Exp Rheumatol , vol.31 , pp. 234-42
    • Stojanovich, L.1    Kontic, M.2    Djokovic, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.